Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. Mf2udh4quf
2. 282103-25-7
3. Refchem:1088895
4. 5-meo-dmt Benzoate
5. Methoxybufotenin Benzoate
6. Methylbufotenine Benzoate
7. Orb2814845
8. Schembl25329816
9. N,n-dimethyl-5-methoxytryptamine Benzoate
10. 1h-indole-3-ethanamine, 5-methoxy-n,n-dimethyl-, Monobenzoate
11. 1h-indole-3-ethanamine, 5-methoxy-n,n-dimethyl-, Benzoate (1:1)
| Molecular Weight | 340.4 g/mol |
|---|---|
| Molecular Formula | C20H24N2O3 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 4 |
| Rotatable Bond Count | 5 |
| Exact Mass | Da |
| Monoisotopic Mass | Da |
| Topological Polar Surface Area | 65.6 |
| Heavy Atom Count | 25 |
| Formal Charge | 0 |
| Complexity | 323 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
NEWS #PharmaBuzz
ABOUT THIS PAGE
45
PharmaCompass offers a list of Mebufotenin benzoate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Mebufotenin benzoate manufacturer or Mebufotenin benzoate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Mebufotenin benzoate manufacturer or Mebufotenin benzoate supplier.
A Mebufotenin benzoate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Mebufotenin benzoate, including repackagers and relabelers. The FDA regulates Mebufotenin benzoate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Mebufotenin benzoate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Mebufotenin benzoate supplier is an individual or a company that provides Mebufotenin benzoate active pharmaceutical ingredient (API) or Mebufotenin benzoate finished formulations upon request. The Mebufotenin benzoate suppliers may include Mebufotenin benzoate API manufacturers, exporters, distributors and traders.
Mebufotenin benzoate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Mebufotenin benzoate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Mebufotenin benzoate GMP manufacturer or Mebufotenin benzoate GMP API supplier for your needs.
A Mebufotenin benzoate CoA (Certificate of Analysis) is a formal document that attests to Mebufotenin benzoate's compliance with Mebufotenin benzoate specifications and serves as a tool for batch-level quality control.
Mebufotenin benzoate CoA mostly includes findings from lab analyses of a specific batch. For each Mebufotenin benzoate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Mebufotenin benzoate may be tested according to a variety of international standards, such as European Pharmacopoeia (Mebufotenin benzoate EP), Mebufotenin benzoate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Mebufotenin benzoate USP).
